Hepatorenal syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Hepatorenal syndrome}} {{CMG}} ==Overview== ==Secondary Prevention== ===Intravenous albumin=== A randomized controlled trial found that intravenous albumin on..." |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatorenal syndrome}} | {{Hepatorenal syndrome}} | ||
{{CMG}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
===Intravenous albumin=== | ===Intravenous albumin=== | ||
A [[randomized controlled trial]] found that intravenous albumin on the day of admission and on hospital day 3 can reduce renal impairment.<ref name="pmid10432325">{{cite journal |author=Sort P, Navasa M, Arroyo V, ''et al'' |title=Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis |journal=N. Engl. J. Med. |volume=341 |issue=6 |pages=403-9 |year=1999 |pmid=10432325 |doi=}}</ref> | A [[randomized controlled trial]] found that intravenous albumin on the day of admission and on hospital day 3 can reduce renal impairment.<ref name="pmid10432325">{{cite journal |author=Sort P, Navasa M, Arroyo V, ''et al'' |title=Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis |journal=N. Engl. J. Med. |volume=341 |issue=6 |pages=403-9 |year=1999 |pmid=10432325 |doi=}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Hepatology]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Revision as of 13:09, 18 July 2016
|
Hepatorenal syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatorenal syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatorenal syndrome secondary prevention |
|
Risk calculators and risk factors for Hepatorenal syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Secondary Prevention
Intravenous albumin
A randomized controlled trial found that intravenous albumin on the day of admission and on hospital day 3 can reduce renal impairment.[1]